Methyldopa
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
C10H13NO4 . 1½H2O 238.24
C10H13NO4 211.22
L-Tyrosine, 3-hydroxy-a-methyl-, sesquihydrate;
L-3-(3,4-Dihydroxyphenyl)-2-methylalanine sesquihydrate CAS RN®: 41372-08-1; UNII: 56LH93261Y.
Anhydrous CAS RN®: 555-30-6; UNII: M4R0H12F6M.
1 DEFINITION
Methyldopa contains NLT 98.0% and NMT 102.0% of methyldopa (C10H13NO4), calculated on the anhydrous basis.
2 IDENTIFICATION
A. SPECTROSCOPIC IDENTIFICATION TESTS (197), Infrared Spectroscopy: 197A or 197K
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
3.1 PROCEDURE
[NOTE-Freshly prepare the Standard solution and Sample solution before use.]
Buffer: 0.1 M monobasic sodium phosphate. Adjust with phosphoric acid to a pH of 3.0.
Mobile phase: Buffer and methanol (850:150)
Diluent: 0.1 N hydrochloric acid
Standard solution: 0.4 mg/mL of USP Methyldopa RS in Diluent
Sample solution: 0.4 mg/mL of Methyldopa in Diluent
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 280 nm
Column: 4.6-mm x 25-cm; 5-µm packing L1
Flow rate: 1.0 mL/min
Injection volume: 20 µL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: 0.9-1.5
Relative standard deviation: NMT 0.73%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of methyldopa (C10H13NO4) in the portion of Methyldopa taken:
Result = (rU/rS) x (CS/CU) × 100
rU = peak response of methyldopa from the Sample solution
rS = peak response of methyldopa from the Standard solution
CS = concentration of USP Methyldopa RS in the Standard solution (mg/mL)
CU = concentration of Methyldopa in the Sample solution (mg/mL)
Acceptance criteria: 98.0%-102.0% on the anhydrous basis
4 IMPURITIES
RESIDUE ON IGNITION (281): NMT 0.1%
ORGANIC IMPURITIES
[NOTE-Freshly prepare the Standard solution and Sample solution before use.]
Buffer, Mobile phase, and Diluent: Prepare as directed in the Assay.
System suitability solution: 4 µg/mL of USP Methyldopa RS and 6 µg/mL each of USP 3-0-Methylmethyldopa RS, USP Methyldopa Related Compound B RS, and USP Methyldopa Related Compound C RS in Diluent
Standard solution: 4 µg/mL of USP Methyldopa RS in Diluent
Sample solution: 4 mg/mL of Methyldopa in Diluent
Chromatographic system: Proceed as directed in the Assay, except for the Run time.
Run time: NLT 6 times the retention time of methyldopa
System suitability
Samples: System suitability solution and Standard solution
Suitability requirements
Resolution: NLT 2.0 between methyldopa related compound B and methyldopa related compound C, System suitability solution
Relative standard deviation: NMT 5%, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of each impurity in the portion of Methyldopa taken:
Result = (rU/rS) x (CS/CU) × (1/F) × 100
rU = peak response of each impurity from the Sample solution
rS = peak response of methyldopa from the Standard solution
CS = concentration of USP Methyldopa RS in the Standard solution (mg/mL)
CU = concentration of Methyldopa in the Sample solution (mg/mL)
Acceptance criteria: See Table 1. Disregard any peaks below 0.03%.
Table 1
| Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) |
| Methyldopa | 1.0 | 1.0 | - |
| 3-O-Methylmethyldopaᵃ | 1.9 | 1.0 | 0.15 |
| Methyldopa related compound Bᵇ | 4.3 | 0.38 | 0.15 |
| Methyldopa related compound Cᶜ | 4.9 | 0.77 | 0.15 |
| Any individual unspecified impurity | - | 1.0 | 0.05 |
| Total impurities | - | - | 0.5 |
a (S)-2-Amino-3-(4-hydroxy-3-methoxyphenyl)-2-methylpropanoic acid.
b (S)-2-Amino-3-(4-methoxyphenyl)-2-methylpropanoic acid.
c (S)-2-Amino-3-(3,4-dimethoxyphenyl)-2-methylpropanoic acid.
5 SPECIFIC TESTS
OPTICAL ROTATION (781S), Procedures, Specific Rotation
Sample solution: 44 mg/mL, in a solvent that is a solution of aluminum chloride hexahydrate in water (2 in 3) that previously has been treated with activated charcoal, filtered, and adjusted with 0.25 N sodium hydroxide to a pH of 1.5
Acceptance criteria: -25° to -28°
ACIDITY
Sample solution: Dissolve 1.0 g in carbon dioxide-free water with the aid of heat, and add 1 drop of methyl red TS.
Analysis: Titrate the Sample solution with 0.10 N sodium hydroxide to a yellow endpoint.
Acceptance criteria: NMT 0.50 mL is required.
WATER DETERMINATION (921), Method I: 10.0%~13.0%
6 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in well-closed, light-resistant containers.
Change to read:
USP REFERENCE STANDARDS (11)
USP Methyldopa RS
USP Methyldopa Related Compound B RS
(S)-2-Amino-3-(4-methoxyphenyl)-2-methylpropanoic acid hydrochloride.
C11H15NO3 . HCl 245.70
USP Methyldopa Related Compound C RS
(S)-2-Amino-3-(3,4-dimethoxyphenyl)-2-methylpropanoic acid hydrochloride.
C12H17NO4 . HCl 275.73
USP 3-O-Methylmethyldopa RS
(S)-2-Amino-3-(4-hydroxy-3-methoxyphenyl)-2-methylpropanoic acid monohydrate. (CN 1-Aug-2023)
C11H15NO4 . H2O 243.26 (CN 1-Aug-2023)

